Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 07, 2023

SELL
$0.57 - $1.08 $41,553 - $78,732
-72,900 Reduced 98.43%
1,165 $1,000
Q4 2022

Jan 30, 2023

SELL
$1.1 - $2.45 $112 - $249
-102 Reduced 0.14%
74,065 $92,000
Q3 2022

Nov 08, 2022

BUY
$1.96 - $3.32 $946 - $1,603
483 Added 0.66%
74,167 $153,000
Q2 2022

Aug 04, 2022

SELL
$2.27 - $4.86 $631 - $1,351
-278 Reduced 0.38%
73,684 $204,000
Q1 2022

May 05, 2022

SELL
$3.69 - $5.65 $185,134 - $283,471
-50,172 Reduced 40.42%
73,962 $323,000
Q4 2021

Feb 02, 2022

SELL
$5.37 - $7.07 $5,187 - $6,829
-966 Reduced 0.77%
124,134 $685,000
Q3 2021

Nov 02, 2021

SELL
$5.54 - $7.51 $85,183 - $115,473
-15,376 Reduced 10.95%
125,100 $773,000
Q2 2021

Aug 02, 2021

SELL
$7.78 - $11.4 $107,550 - $157,593
-13,824 Reduced 8.96%
140,476 $1.19 Million
Q1 2021

May 11, 2021

BUY
$5.12 - $8.48 $36,495 - $60,445
7,128 Added 4.84%
154,300 $1.22 Million
Q4 2020

Feb 08, 2021

BUY
$3.16 - $7.03 $320,335 - $712,645
101,372 Added 221.34%
147,172 $857,000
Q3 2020

Nov 05, 2020

SELL
$3.26 - $4.73 $103,762 - $150,551
-31,829 Reduced 41.0%
45,800 $155,000
Q2 2020

Aug 07, 2020

SELL
$1.58 - $4.63 $68,959 - $202,076
-43,645 Reduced 35.99%
77,629 $358,000
Q3 2019

Nov 07, 2019

SELL
$2.67 - $3.65 $41,919 - $57,305
-15,700 Reduced 11.46%
121,274 $357,000
Q2 2019

Aug 09, 2019

BUY
$2.6 - $4.21 $356,132 - $576,660
136,974 New
136,974 $393,000

Others Institutions Holding AFMD

About Affimed N.V.


  • Ticker AFMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 149,339,008
  • Market Cap $185M
  • Description
  • Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in P...
More about AFMD
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.